Study Stopped
Incomplete follow up, low enrollment
A Pilot Project for Multifidus Muscle Evaluation in Patients With Multiple Sclerosis
1 other identifier
interventional
7
1 country
1
Brief Summary
This research study plans to evaluate if multifidus muscle dysfunction is associated with back pain in patients with Multiple Sclerosis (MS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 23, 2022
CompletedFirst Posted
Study publicly available on registry
June 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2023
CompletedResults Posted
Study results publicly available
November 7, 2024
CompletedNovember 7, 2024
February 1, 2024
1 year
May 23, 2022
February 8, 2024
November 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Study the Compliance of a Home-exercise Program in Patients With MS
we will evaluate how many exercise sessions patients do at home versus what was purposed to the patient.
6 months
Secondary Outcomes (3)
Qualify the Multifidus Dysfunction in Patients With MS - Ultrasound
6 months
Qualify the Multifidus Dysfunction in Patients With MS - Physical Exam
6 months
Correlation Between Compliance and Plain and Size of Muscle
6 months
Study Arms (1)
Intervention group
EXPERIMENTALAdult patients \< 50 years old who have multiple sclerosis and back pain who are undergoing home exercise
Interventions
Eligibility Criteria
You may qualify if:
- confirmed diagnosis by an UAMS neuro-immunologist of relapsing-remitting MS or primary progressive MS or secondary progressive MS
- Age between 18 years old and 50 years old on consent
- Complain of low back pain or severe axial back pain
- English-speaking
You may not qualify if:
- Patients that also have the diagnosis of thoracic or lumbar radiculopathy or history of prior thoracic or lumbar spinal surgery.
- Patients that are currently pregnant EDSS over 5.5 or less than 1.0 Patient younger than 18 years old or older than 50 years old Knee total extension of less than 100 degrees
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Santos-Horta
- Organization
- UArkansas
Study Officials
- PRINCIPAL INVESTIGATOR
Erika Santos Horta, MD
University of Arkansas
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2022
First Posted
June 22, 2022
Study Start
May 1, 2022
Primary Completion
May 5, 2023
Study Completion
May 5, 2023
Last Updated
November 7, 2024
Results First Posted
November 7, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share